Haptoglobin and Preeclampsia

This study has been completed.
Sponsor:
Information provided by:
Bnai Zion Medical Center
ClinicalTrials.gov Identifier:
NCT01027130
First received: December 4, 2009
Last updated: NA
Last verified: December 2009
History: No changes posted
  Purpose

The purpose of this study is to show that a certain protein called haptoglobin protects against preeclampsia which is a common pregnancy complication.


Condition
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Bnai Zion Medical Center:

Groups/Cohorts
healthy control
240 female subjects without preeclampsia
preeclampsia
120 female subjects with preeclampsia

  Eligibility

Genders Eligible for Study:   Female
Sampling Method:   Non-Probability Sample
Study Population

women coming to give birth at our medical center

Criteria

Inclusion Criteria:

  • all women

Exclusion Criteria:

  • women with hypertension
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01027130

Locations
Israel
Bnai-Zion Medical Center
Haifa, Israel, 33393
Sponsors and Collaborators
Bnai Zion Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01027130     History of Changes
Other Study ID Numbers: HAPPET
Study First Received: December 4, 2009
Last Updated: December 4, 2009
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on April 17, 2014